Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dong-Kug Choi

Showing results (61-70 of 167) with videos related to

Pageof 17
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|November 5, 2019
Targeting the microglial NLRP3 inflammasome and its role in Parkinson's diseaseMd Ezazul Haque, Mahbuba Akther, Md Jakaria, et al.
Antioxidants (Basel, Switzerland)|January 30, 2020
Medicinal Profile, Phytochemistry, and Pharmacological Activities of Murraya koenigii and its Primary Bioactive CompoundsRengasamy Balakrishnan, Dhanraj Vijayraja, Song-Hee Jo, et al.
Chemmedchem|April 19, 2026
Synthesis of Acrylamide Analogs of Rimonabant and Evaluation of Anti-Inflammatory Activities by Inhibiting NF-κB and MAPK Signaling Pathways in Lipopolysaccharide-Induced BV2 CellsSung-Hwa Yoon, Jun-Hyuk Han, Young-Min Lee, et al.
Biochemical and Biophysical Research Communications|May 24, 2003
Isolation and expression of Napor/CUG-BP2 in embryo developmentDong-Kug Choi, Kyeong-Won Yoo, Sung-Kook Hong, et al.
International Journal of Molecular Sciences|September 6, 2012
Recent advances on the neuroprotective potential of antioxidants in experimental models of Parkinson's diseaseSushruta Koppula, Hemant Kumar, Sandeep Vasant More, et al.
CNS & Neurological Disorders Drug Targets|March 9, 2013
Strategic selection of neuroinflammatory models in Parkinson's disease: evidence from experimental studiesSandeep Vasant More, Hemant Kumar, In-Su Kim, et al.
Cells|November 24, 2023
The Neuropharmacological Evaluation of Seaweed: A Potential Therapeutic SourceKhoshnur Jannat, Rengasamy Balakrishnan, Jun-Hyuk Han, et al.
International Journal of Molecular Sciences|August 10, 2017
Comparative Studies on Behavioral, Cognitive and Biomolecular Profiling of ICR, C57BL/6 and Its Sub-Strains Suitable for Scopolamine-Induced Amnesic ModelsGovindarajan Karthivashan, Shin-Young Park, Joon-Soo Kim, et al.
International Journal of Molecular Sciences|April 30, 2021
The Neuroprotective Effects of GPR4 Inhibition through the Attenuation of Caspase Mediated Apoptotic Cell Death in an MPTP Induced Mouse Model of Parkinson's DiseaseMd Ezazul Haque, Shofiul Azam, Mahbuba Akther, et al.
CNS & Neurological Disorders Drug Targets|December 19, 2012
Nuclear factor erythroid 2-related factor 2 signaling in Parkinson disease: a promising multi therapeutic target against oxidative stress, neuroinflammation and cell deathHemant Kumar, Sushruta Koppula, In-Su Kim, et al.
Pageof 17

Showing results (61-70 of 167) with videos related to

Sort By:
Pageof 17
Movement Disorders : Official Journal of the Movement Disorder Society|November 5, 2019
Targeting the microglial NLRP3 inflammasome and its role in Parkinson's diseaseMd Ezazul Haque, Mahbuba Akther, Md Jakaria, et al.
Antioxidants (Basel, Switzerland)|January 30, 2020
Medicinal Profile, Phytochemistry, and Pharmacological Activities of Murraya koenigii and its Primary Bioactive CompoundsRengasamy Balakrishnan, Dhanraj Vijayraja, Song-Hee Jo, et al.
Chemmedchem|April 19, 2026
Synthesis of Acrylamide Analogs of Rimonabant and Evaluation of Anti-Inflammatory Activities by Inhibiting NF-κB and MAPK Signaling Pathways in Lipopolysaccharide-Induced BV2 CellsSung-Hwa Yoon, Jun-Hyuk Han, Young-Min Lee, et al.
Biochemical and Biophysical Research Communications|May 24, 2003
Isolation and expression of Napor/CUG-BP2 in embryo developmentDong-Kug Choi, Kyeong-Won Yoo, Sung-Kook Hong, et al.
International Journal of Molecular Sciences|September 6, 2012
Recent advances on the neuroprotective potential of antioxidants in experimental models of Parkinson's diseaseSushruta Koppula, Hemant Kumar, Sandeep Vasant More, et al.
CNS & Neurological Disorders Drug Targets|March 9, 2013
Strategic selection of neuroinflammatory models in Parkinson's disease: evidence from experimental studiesSandeep Vasant More, Hemant Kumar, In-Su Kim, et al.
Cells|November 24, 2023
The Neuropharmacological Evaluation of Seaweed: A Potential Therapeutic SourceKhoshnur Jannat, Rengasamy Balakrishnan, Jun-Hyuk Han, et al.
International Journal of Molecular Sciences|August 10, 2017
Comparative Studies on Behavioral, Cognitive and Biomolecular Profiling of ICR, C57BL/6 and Its Sub-Strains Suitable for Scopolamine-Induced Amnesic ModelsGovindarajan Karthivashan, Shin-Young Park, Joon-Soo Kim, et al.
International Journal of Molecular Sciences|April 30, 2021
The Neuroprotective Effects of GPR4 Inhibition through the Attenuation of Caspase Mediated Apoptotic Cell Death in an MPTP Induced Mouse Model of Parkinson's DiseaseMd Ezazul Haque, Shofiul Azam, Mahbuba Akther, et al.
CNS & Neurological Disorders Drug Targets|December 19, 2012
Nuclear factor erythroid 2-related factor 2 signaling in Parkinson disease: a promising multi therapeutic target against oxidative stress, neuroinflammation and cell deathHemant Kumar, Sushruta Koppula, In-Su Kim, et al.
Pageof 17